Subtitle 2C - PRESCRIPTION DRUG AFFORDABILITY BOARD
- Section 21-2C-01 - Definitions
- Section 21-2C-02 - Prescription Drug Affordability Board
- Section 21-2C-03 - Membership
- Section 21-2C-04 - Prescription Drug Affordability Stakeholder Council
- Section 21-2C-05 - Disclosure of conflicts of interest
- Section 21-2C-06 - Acceptance of gratuities prohibited
- Section 21-2C-07 - Study and report - Pharmaceutical distribution and payment system in State; policy options used in other states and countries
- Section 21-2C-08 - Collection, review, and use of transparency data for prescription drug products
- Section 21-2C-09 - Cost review of prescription drug products with affordability challenges
- Section 21-2C-10 - Confidentiality
- Section 21-2C-11 - Funding source
- Section 21-2C-12 - Enforcement
- Section 21-2C-13 - Setting upper payment limits for prescription drug products
- Section 21-2C-14 - Action by board
- Section 21-2C-15 - Appeal
- Section 21-2C-16 - Board and Stakeholder Council report and recommendation concerning upper payment limits